Matches in Wikidata for { <http://www.wikidata.org/entity/Q86246058> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q86246058 description "clinical trial" @default.
- Q86246058 description "ensayu clínicu" @default.
- Q86246058 description "klinisch onderzoek" @default.
- Q86246058 description "клінічне випробування" @default.
- Q86246058 name "Itacitinib for the Treatment of Bronchiolitis Obliterans Syndrome After Donor Hematopoietic Cell Transplant" @default.
- Q86246058 name "Itacitinib for the Treatment of Bronchiolitis Obliterans Syndrome After Donor Hematopoietic Cell Transplant" @default.
- Q86246058 type Item @default.
- Q86246058 label "Itacitinib for the Treatment of Bronchiolitis Obliterans Syndrome After Donor Hematopoietic Cell Transplant" @default.
- Q86246058 label "Itacitinib for the Treatment of Bronchiolitis Obliterans Syndrome After Donor Hematopoietic Cell Transplant" @default.
- Q86246058 prefLabel "Itacitinib for the Treatment of Bronchiolitis Obliterans Syndrome After Donor Hematopoietic Cell Transplant" @default.
- Q86246058 prefLabel "Itacitinib for the Treatment of Bronchiolitis Obliterans Syndrome After Donor Hematopoietic Cell Transplant" @default.
- Q86246058 P1050 Q86246058-3E90CA13-09B6-4EF7-8533-245B333EE50C @default.
- Q86246058 P1050 Q86246058-A7038491-868F-4B0A-AD42-2F87BCA43EE4 @default.
- Q86246058 P1132 Q86246058-C3B867CD-BBA8-4455-9709-2A3C67994EBD @default.
- Q86246058 P1476 Q86246058-742E088B-7F98-427A-83D3-3CFFD069A179 @default.
- Q86246058 P17 Q86246058-82DFD93C-F37B-49C1-A23D-F8877B3E9252 @default.
- Q86246058 P2899 Q86246058-1D133FAB-01BE-42B8-B164-83AC447AA792 @default.
- Q86246058 P3098 Q86246058-5344EEC8-AADD-4336-93A4-2FF623C764D2 @default.
- Q86246058 P31 Q86246058-7A41BDE9-9495-4AEF-996B-ACC2F40F343C @default.
- Q86246058 P4135 Q86246058-EE18E15F-DE1B-4111-B07D-2EE1BE758198 @default.
- Q86246058 P580 Q86246058-76E3A474-817D-4F4C-9D49-C38EA6B18EBD @default.
- Q86246058 P582 Q86246058-3D2C37D5-8D7A-4518-8F96-047CEA491C8F @default.
- Q86246058 P6099 Q86246058-A027A9CC-AB3D-4A3C-8E68-80C9BDD4D7B0 @default.
- Q86246058 P767 Q86246058-1A6605E7-0110-4527-BC21-61BFBD357A37 @default.
- Q86246058 P8363 Q86246058-2F8EF524-00F3-4B80-9FDD-C08F0962FE6A @default.
- Q86246058 P859 Q86246058-75D6E2C6-D0A2-4AD8-8938-A10D040C50B4 @default.
- Q86246058 P1050 Q424227 @default.
- Q86246058 P1050 Q614750 @default.
- Q86246058 P1132 "+15" @default.
- Q86246058 P1476 "A Phase I Study to Assess Safety of Selective JAK 1 Inhibitor, Itacitinib, in Patients With Bronchiolitis Obliterans Syndrome (BOS) After Allogeneic Hematopoietic Cell Transplant (HCT)" @default.
- Q86246058 P17 Q30 @default.
- Q86246058 P2899 "+18" @default.
- Q86246058 P3098 "NCT04239989" @default.
- Q86246058 P31 Q30612 @default.
- Q86246058 P4135 "+75" @default.
- Q86246058 P580 "2020-05-31T00:00:00Z" @default.
- Q86246058 P582 "2022-04-01T00:00:00Z" @default.
- Q86246058 P6099 Q5452194 @default.
- Q86246058 P767 Q664846 @default.
- Q86246058 P8363 Q78089383 @default.
- Q86246058 P859 Q1525831 @default.